Home › Forums › Questions › Shifting from SMOF to intralipid › …
July 11, 2017 at 11:05 am
#49167
Rachel Phillips
Participant
There is a good reference at the ASPEN portal dealing with product shortages, it explains some strategies to save the remaining little stock for certain patient categories, also alternatives if applicable.
I think being proactive against product shortages is one of the biggest challenges we face all the time.